Local Phone: 0845 260 2602
CNX Therapeutics has acquired the global Sativex® (nabiximols) business from Jazz Pharmaceuticals, reinforcing its position in the central nervous...
Read MoreSanthera Pharmaceuticals has reported positive topline results from a long-term analysis of AGAMREE (vamorolone) in boys with Duchenne muscular...
Read MoreIncyte has unveiled promising new data from its phase 3b TRuE-AD4 study of Opzelura (ruxolitinib cream 1.5%) in adults...
Read MoreSonoma Biotherapeutics has reported positive interim findings from its ongoing phase 1 REGULATE-RA trial of SBT-77-7101, an investigational cell...
Read MoreAstellas Pharma has unveiled encouraging preliminary results from OPTION-VMS, its ongoing phase 4 observational study evaluating fezolinetant in women...
Read MoreENA Respiratory has closed a US$22.4 million (AU$34 million) Series B round to propel its lead therapy, INNA-051, into...
Read More
